171 related articles for article (PubMed ID: 26507395)
1. Antimicrobial Resistance of Escherichia coli Causing Uncomplicated Urinary Tract Infections: A European Update for 2014 and Comparison with 2000 and 2008.
Kahlmeter G; Åhman J; Matuschek E
Infect Dis Ther; 2015 Dec; 4(4):417-23. PubMed ID: 26507395
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
Kahlmeter G; Poulsen HO
Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial resistances in uncomplicated urinary tract infections in women: ECO·SENS II data from primary health care in Austria.
Kamenski G; Wagner G; Zehetmayer S; Fink W; Spiegel W; Hoffmann K
BMC Infect Dis; 2012 Sep; 12():222. PubMed ID: 22989349
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia.
Ny S; Edquist P; Dumpis U; Gröndahl-Yli-Hannuksela K; Hermes J; Kling AM; Klingeberg A; Kozlov R; Källman O; Lis DO; Pomorska-Wesołowska M; Saule M; Wisell KT; Vuopio J; Palagin I;
J Glob Antimicrob Resist; 2019 Jun; 17():25-34. PubMed ID: 30447337
[TBL] [Abstract][Full Text] [Related]
5. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
Zhanel GG; Karlowsky JA; Schwartz B; Jensen SB; Hoban DJ
Chemotherapy; 1998; 44(6):391-6. PubMed ID: 9755298
[TBL] [Abstract][Full Text] [Related]
6. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project.
Kahlmeter G;
J Antimicrob Chemother; 2003 Jan; 51(1):69-76. PubMed ID: 12493789
[TBL] [Abstract][Full Text] [Related]
7. Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in
Kresken M; Pfeifer Y; Wagenlehner F; Werner G; Wohlfarth E; Therapy OBOSG'ROTPESFI
Antibiotics (Basel); 2022 May; 11(6):. PubMed ID: 35740157
[TBL] [Abstract][Full Text] [Related]
8. The ECO*SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report.
Kahlmeter G
J Antimicrob Chemother; 2000 Aug; 46 Suppl A():15-22. PubMed ID: 10969047
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic Resistance Among Uropathogenic
Kot B
Pol J Microbiol; 2019 Dec; 68(4):403-415. PubMed ID: 31880885
[TBL] [Abstract][Full Text] [Related]
10. SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study.
Tutone M; Bjerklund Johansen TE; Cai T; Mushtaq S; Livermore DM
Int J Antimicrob Agents; 2022 May; 59(5):106574. PubMed ID: 35307561
[TBL] [Abstract][Full Text] [Related]
11. [In-vitro activity of mecillinam against urine isolates of Escherichia coli from outpatient departments in Germany].
Kresken M; Körber-Irrgang B; Naber KG
Aktuelle Urol; 2017 May; 48(3):243-247. PubMed ID: 28427111
[TBL] [Abstract][Full Text] [Related]
12. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.
Zhanel GG; Karlowsky JA; Harding GK; Carrie A; Mazzulli T; Low DE; Hoban DJ
Antimicrob Agents Chemother; 2000 Apr; 44(4):1089-92. PubMed ID: 10722520
[TBL] [Abstract][Full Text] [Related]
13. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM
J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
[TBL] [Abstract][Full Text] [Related]
15. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.
Schito GC; Naber KG; Botto H; Palou J; Mazzei T; Gualco L; Marchese A
Int J Antimicrob Agents; 2009 Nov; 34(5):407-13. PubMed ID: 19505803
[TBL] [Abstract][Full Text] [Related]
16. High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread.
Poulsen HO; Johansson A; Granholm S; Kahlmeter G; Sundqvist M
J Antimicrob Chemother; 2013 Sep; 68(9):1974-7. PubMed ID: 23640126
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic treatment failure of uncomplicated urinary tract infections in primary care.
Koh SWC; Ng TSM; Loh VWK; Goh JC; Low SH; Tan WZ; Wong HC; Durai P; Sun LJ; Young D; Tambyah PA
Antimicrob Resist Infect Control; 2023 Aug; 12(1):73. PubMed ID: 37528415
[TBL] [Abstract][Full Text] [Related]
18. The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.
Zykov IN; Sundsfjord A; Småbrekke L; Samuelsen Ø
Infect Dis (Lond); 2016 Feb; 48(2):99-107. PubMed ID: 26414659
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance in urinary pathogens among Swedish nursing home residents remains low: a cross-sectional study comparing antimicrobial resistance from 2003 to 2012.
Sundvall PD; Elm M; Gunnarsson R; Mölstad S; Rodhe N; Jonsson L; Ulleryd P
BMC Geriatr; 2014 Mar; 14():30. PubMed ID: 24625344
[TBL] [Abstract][Full Text] [Related]
20. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim report.
Kahlmeter G
J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():15-22; discussion 63-5. PubMed ID: 11051619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
